ROIV
Roivant Sciences Ltd. · Healthcare
President and COO Eric Venker sold $1.0M of Roivant Sciences Ltd.
Sold$1,019,736
$7.03Price
145,105Shares
−14%Stake
What ROIV did after the filing
- The stock from Mon, Dec 12 open, $6.99
- +19.7%
- S&P 500, same days
- +3.2%
Measured over 30 trading days, to the Jan 26 close.
Traded Thu, Dec 8. Filed Fri, Dec 9, 9:30 PM ET, after the close. Returns use the Dec 12 open and the Jan 26 close. Not investment advice.